TCIM
BSX icon

TIAA CREF Investment Management’s Boston Scientific BSX Stock Holding History

TIAA CREF Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$263M Buy
6,861,091
+640,207
+10% +$24.5M 0.19% 109
2018
Q4 		$220M Buy
6,220,884
+166,664
+3% +$6.04M 0.17% 123
2018
Q3 		$233M Sell
6,054,220
-2,416,913
-29% -$84.4M 0.15% 142
2018
Q2 		$277M Buy
8,471,133
+201,512
+2% +$6.08M 0.19% 120
2018
Q1 		$226M Sell
8,269,621
-432,683
-5% -$11.8M 0.15% 138
2017
Q4 		$216M Sell
8,702,304
-282,427
-3% -$7.79M 0.14% 151
2017
Q3 		$262M Sell
8,984,731
-648,079
-7% -$17.9M 0.18% 122
2017
Q2 		$267M Buy
9,632,810
+158,417
+2% +$4.2M 0.19% 115
2017
Q1 		$236M Buy
9,474,393
+2,380,210
+34% +$57.9M 0.17% 123
2016
Q4 		$153M Sell
7,094,183
-335,282
-5% -$7.32M 0.11% 186
2016
Q3 		$177K Sell
7,429,465
-1,236,409
-14% -$29.5M 0.11% 182
2016
Q2 		$203M Buy
8,665,874
+921,490
+12% +$19.9M 0.16% 133
2016
Q1 		$146M Buy
7,744,384
+745,598
+11% +$13.1M 0.11% 184
2015
Q4 		$129M Buy
6,998,786
+596,650
+9% +$10.7M 0.1% 216
2015
Q3 		$105M Sell
6,402,136
-399,230
-6% -$6.82M 0.08% 250
2015
Q2 		$120M Sell
6,801,366
-3,385,825
-33% -$60.5M 0.09% 248
2015
Q1 		$181M Buy
10,187,191
+4,628,472
+83% +$73.1M 0.13% 189
2014
Q4 		$73.7M Buy
5,558,719
+1,023,562
+23% +$13.1M 0.05% 381
2014
Q3 		$53.6M Sell
4,535,157
-1,471,674
-25% -$18.5M 0.04% 458
2014
Q2 		$76.7M Sell
6,006,831
-972,934
-14% -$12.7M 0.05% 368
2014
Q1 		$94.4M Buy
6,979,765
+602,416
+9% +$7.91M 0.07% 322
2013
Q4 		$76.7M Buy
6,377,349
+1,217,111
+24% +$14.4M 0.06% 365
2013
Q3 		$60.6M Sell
5,160,238
-709,388
-12% -$7.67M 0.05% 415
2013
Q2 		$54.4M Buy
+5,869,626
New +$49.8M 0.04% 427

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

TIAA CREF Investment Management's BSX Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Boston Scientific (BSX) stake by 10% in Q1 2019, buying an estimated $24.5M and bringing the position to 6,861,091 shares worth $263M. The position accounts for 0.19% of the portfolio, ranked #109.

TIAA CREF Investment Management first reported a position in BSX in Q2 2013 and has held it in 24 quarters since. The position peaked at $277M in Q2 2018. 788 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

  • TIAA CREF Investment Management held 6,861,091 shares of Boston Scientific worth $263M as of Q1 2019.
  • TIAA CREF Investment Management bought 640,207 Boston Scientific shares in Q1 2019, an estimated $24.5M.
  • Boston Scientific made up 0.19% of TIAA CREF Investment Management's portfolio in Q1 2019, its #109 holding.
  • TIAA CREF Investment Management first reported a position in Boston Scientific in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Boston Scientific position peaked at $277M in Q2 2018.
  • 788 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.